ArticlePloS one2015

Single and Multiple Dose Pharmacokinetics, Pharmacodynamics and Safety of the Novel Lipoprotein-Associated Phospholipase A2 Enzyme Inhibitor Darapladib in Healthy Chinese Subjects: An Open Label Phase-1 Clinical Trial.

Chaoying Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.